DiaMedica Therapeutics Inc. (DMAC) Q4 2024 Earnings Call Transcript

Stock Information for DiaMedica Therapeutics Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About DiaMedica Therapeutics Inc.

DiaMedica Therapeutics Reports First Quarter 2025 Financial Results And Provides Business Highlights
DiaMedica Therapeutics to Participate in Upcoming Investor Conferences in May
DiaMedica Therapeutics to Report First Quarter 2025 Financial Results and Provide a Business Update May 14, 2025
DiaMedica Therapeutics Provides a Business Update and Announces Full Year 2024 Financial Results
DiaMedica Therapeutics to Report Fourth Quarter 2024 Financial Results and Provide a Business Update March 18, 2025
DiaMedica Therapeutics Appoints Daniel J. O'Connor to the Board of Directors
DiaMedica Therapeutics Announces Publication of DM199's Mechanism of Action for the Treatment of Acute Ischemic Stroke (AIS) in the Journal Stroke
DiaMedica Therapeutics to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.